Equities

Gabelli Healthcare & WellnessRx Trust

GRX:NYQ

Gabelli Healthcare & WellnessRx Trust

Actions
FinancialsClosed End Investments
  • Price (USD)10.89
  • Today's Change-0.03 / -0.27%
  • Shares traded432.00
  • 1 Year change+28.57%
  • Beta1.0471
Data delayed at least 15 minutes, as of Oct 07 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Gabelli Healthcare & WellnessRx Trust (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is long term growth of capital. It is focused on investing approximately 80% of its assets in equity securities and income producing securities of domestic and foreign companies in the healthcare and wellness industries. The Fund invests in various geographic regions, including North America, Europe, Japan and Asia/Pacific. The Fund’s portfolio of investments in various sectors include food; healthcare providers and services; pharmaceuticals; healthcare equipment and supplies; beverages; biotechnology; household and personal products; electronics; specialty chemicals, and food and staples retailing. Gabelli Funds, LLC serves as the investment advisor of the Fund.

  • Revenue in USD (TTM)3.79m
  • Net income in USD-5.48m
  • Incorporated2007
  • Employees--
  • Location
    Gabelli Healthcare & WellnessRx TrustOne Corporate CenterRYE 10580-1422United StatesUSA
  • Phone+1 (914) 921-5100
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Credit Suisse Asset Management In FndInc18.01m20.77m163.79m6.007.851.04--9.090.39150.39150.33922.960.0812--3.48--9.364.819.985.0376.1083.66115.2971.63----0.2497122.4516.700.2784216.09----0.2237
MainStreetChamber Holdings Inc0.00-864.62k164.89m0.00---------0.0985-0.09850.00-0.06050.00-------4,093.26-863.98---------------4.42--------87.21------
Mountain & Co I Acquisition Corp0.003.96m165.46m--51.162.0760.85--0.22790.22790.005.640.00------3.51--3.68--------------0.0596------283.94------
Putnam Master Intermediate Income Trust11.14m10.05m165.53m--16.310.98--14.860.20750.20750.2323.450.0267--0.2084--2.41-0.31653.56-0.476598.4598.1790.27-12.08----0.00---16.39-10.28117.52-24.06---2.39
Rigel Resource Acquisition Corp0.00-1.25m168.17m----1.46-----0.0383-0.03830.007.850.00-------0.4157---0.4278--------------0.0327-------54.09------
Voya Infrstrcture Industrls and Mtrls Fd5.06m20.12m168.39m--8.370.948--33.281.331.330.333911.720.0283--6.00--11.25--11.32--58.62--397.72------0.00---14.84--376.37------
Bexil Investment Trust-100.00bn-100.00bn169.02m--------------------------------------------------------------
Portman Ridge Finance Corp69.23m12.55m169.63m0.0013.910.8651--2.451.321.327.3721.210.1324--26.65--2.401.372.451.4053.9057.2618.1412.02--1.670.590259.359.6323.02154.21-----7.22
PIMCO California Municipal Incom Fnd Iii12.72m5.65m169.75m--30.080.9744--13.340.25100.25100.56577.800.0417------3.301.353.341.3661.4574.5679.0934.46----0.4028353.60-9.27-7.42125.16-----8.10
SK Growth Opportunities Corp0.005.02m170.09m--51.171.8033.91--0.2220.2220.006.330.00------2.99--3.07--------------0.0631------286.11------
Gabelli Healthcare & WellnessRx Trust3.79m-5.48m170.31m----0.9706--44.95-0.3582-0.35820.245811.250.0153--2.78---2.215.04-2.225.10-49.75-24.75-144.67383.38---0.71340.237886.36-1.92-5.00100.89----2.90
Ellington Credit Co47.65m4.17m171.46m170.0043.140.9792--3.600.15690.15692.666.910.0472--1.11280,305.900.41290.15683.061.36-2.4028.318.745.88----0.8028689.7821.55-4.85115.10-----9.88
BurTech Acquisition Corp0.00-945.26k171.49m----5.61-----0.0598-0.05980.002.010.00-------1.57---1.77--------------0.0468-------19.98------
Spark I Acquisition Corp0.00-1.41m172.27m-----------0.1053-0.10530.00-0.1288----------------------------4.33-------193.26------
EVe Mobility Acquisition Corp0.007.05m173.51m--48.883.1438.14--0.22750.22750.003.540.00------4.36--4.39--------------0.0028------761.75------
Eaton Vance New York Municipal Bond Fund-100.00bn-100.00bn176.92m--------------------------------------------------------------
Data as of Oct 07 2024. Currency figures normalised to Gabelli Healthcare & WellnessRx Trust's reporting currency: US Dollar USD

Institutional shareholders

22.51%Per cent of shares held by top holders
HolderShares% Held
Saba Capital Management LPas of 07 Aug 20241.80m11.41%
GAMCO Asset Management, Inc.as of 31 Mar 2024321.21k2.03%
Wells Fargo Clearing Services LLCas of 31 Mar 2024250.57k1.59%
Cetera Investment Advisers LLCas of 31 Mar 2024222.20k1.41%
AQR Arbitrage LLCas of 31 Mar 2024205.25k1.30%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024191.70k1.21%
Beacon Pointe Advisors LLCas of 31 Mar 2024149.40k0.95%
Logan Stone Capital LLCas of 31 Mar 2024145.05k0.92%
Cornerstone Advisors LLC (North Carolina)as of 30 Jun 2024139.69k0.88%
Aviance Capital Partners LLCas of 30 Jun 2024128.08k0.81%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.